Nonpeptide Urotensin-II receptor agonists and antagonists: Review and structure-activity relationships

被引:22
作者
Lescot, Elodie [1 ]
Bureau, Ronan [1 ]
Rault, Sylvain [1 ]
机构
[1] Univ Caen, UFR Sci Pharmaceut, Ctr Etudes & Rech Medicament Normandie, F-14032 Caen, France
关键词
Urotensin-II; GPR14; nonpeptide agonists and antagonists; GPCR; SAR; pharmacophore;
D O I
10.1016/j.peptides.2007.09.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human Urotensin-II (hU-II) is a cyclic 11-amino acid peptide that plays a role in cardiovascular homeostasis. Its receptor is a member of the class A of G-protein-coupled receptors, called GPR14. In recent years, several nonpeptide ligands have been reported in the literature. Most were identified by high-throughput screening and optimized by medicinal chemistry methods. Other nonpeptide ligands were discovered starting from the 3D structure of hU-II or other ligands. They were identified by a virtual screening approach based on a 3D pharmacophore or by structural similarity with others cyclic peptides. in this review, nonpeptide agonists and antagonists are presented in relation to structure-activity relationships. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 690
页数:11
相关论文
共 82 条
  • [1] AISSAOUI H, 2004, Patent No. 2004099179
  • [2] AISSAOUI H, 2002, Patent No. 2002076979
  • [3] AISSAOUI H, 2004, Patent No. 2004099180
  • [4] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    [J]. NATURE, 1999, 401 (6750) : 282 - 286
  • [5] BARTON LS, 2004, Patent No. 2004043917
  • [6] G protein-coupled receptors:: In silico drug discovery in 3D
    Becker, OM
    Marantz, Y
    Shacham, S
    Inbal, B
    Heifetz, A
    Kalid, O
    Bar-Haim, S
    Warshaviak, D
    Fichman, M
    Noiman, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) : 11304 - 11309
  • [7] Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice
    Behm, DJ
    Harrison, SM
    Ao, ZH
    Maniscalco, K
    Pickering, SJ
    Grau, EV
    Woods, TN
    Coatney, RW
    Doe, CPA
    Willette, RN
    Johns, DG
    Douglas, SA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (02) : 464 - 472
  • [8] Nonpeptidic ligands for peptide-activated g protein-coupled receptors
    Blakeney, Jade S.
    Reid, Robert C.
    Le, Giang T.
    Fairlie, David P.
    [J]. CHEMICAL REVIEWS, 2007, 107 (07) : 2960 - 3041
  • [9] Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease
    Bousette, Nicolas
    Pottinger, Julia
    Ramli, Wisam
    Ohlstein, Eliot H.
    Dhanak, Dashyant
    Douglas, Stephen A.
    Giaid, Adel
    [J]. PEPTIDES, 2006, 27 (11) : 2919 - 2926
  • [10] Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation
    Bousette, Nicolas
    Hu, Fu
    Ohlstein, Eliot H.
    Dhanak, Dashyant
    Douglas, Stephen A.
    Giaid, Adel
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (02) : 285 - 295